Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1325 of 1467 entries
View as:

Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants

Phase: N/A Priority: Normal
NCT ID: NCT03664882 Org: User:
Start: 09/17/18 End: 01/03/19 Due: 01/03/20

A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00390650 Org: User:
Start: 10/31/06 End: 11/30/07 Due: 11/30/08

Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01042925 Org: User:
Start: 02/28/10 End: 12/31/12 Due: 12/31/13

A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia

Phase: N/A Priority: Normal
NCT ID: NCT06714448 Org: User:
Start: 04/29/25 End: 11/27/25 Due: 11/27/26

A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia

Phase: N/A Priority: Normal
NCT ID: NCT06714461 Org: User:
Start: 05/05/25 End: 12/03/25 Due: 12/03/26

A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05704049 Org: User:
Start: 04/05/23 End: 05/12/28 Due: 05/12/29

Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT03462017 Org: User:
Start: 03/07/18 End: 12/22/18 Due: 12/22/19

Valproic Acid Sodium Salt in Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00431522 Org: User:
Start: 12/31/04 End: 10/31/06 Due: 10/31/07

Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03275285 Org: User:
Start: 10/25/17 End: 01/03/25 Due: 01/03/26

A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01293630 Org: User:
Start: 01/31/11 End: 10/31/13 Due: 10/31/14

Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01031303 Org: User:
Start: 12/31/09 End: 01/31/11 Due: 01/31/12

Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions

Phase: N/A Priority: Normal
NCT ID: NCT00566657 Org: User:
Start: 11/30/07 End: 08/31/12 Due: 08/31/13

Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00290927 Org: User:
Start: 12/31/03 End: - Due: -

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01140607 Org: User:
Start: 05/31/10 End: 07/31/14 Due: 07/31/15

Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00174824 Org: User:
Start: 06/30/01 End: 04/30/07 Due: 04/30/08

Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00563771 Org: User:
Start: 03/31/03 End: 01/31/04 Due: 01/31/05

A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX

Phase: N/A Priority: Normal
NCT ID: NCT00314145 Org: User:
Start: 11/30/05 End: 11/30/06 Due: 11/30/07

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

Phase: N/A Priority: Normal
NCT ID: NCT04458051 Org: User:
Start: 08/13/20 End: 11/03/25 Due: 11/03/26

Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05071053 Org: User:
Start: 11/16/21 End: 11/05/24 Due: 11/05/25

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization

Phase: N/A Priority: Normal
NCT ID: NCT00077753 Org: User:
Start: 02/28/02 End: 02/28/07 Due: 02/28/08

Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children

Phase: N/A Priority: Normal
NCT ID: NCT02169817 Org: User:
Start: 07/31/14 End: 01/31/16 Due: 01/31/17

Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00327743 Org: User:
Start: 08/31/06 End: 03/31/09 Due: 03/31/10

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)

Phase: N/A Priority: Normal
NCT ID: NCT00050817 Org: User:
Start: 10/31/02 End: 08/31/05 Due: 08/31/06

Insulin Glargine in Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00272077 Org: User:
Start: 04/30/05 End: - Due: -

Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)

Phase: N/A Priority: Normal
NCT ID: NCT00425243 Org: User:
Start: 08/31/04 End: 01/31/06 Due: 01/31/07